Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GED-0507-34-Levo in Active Ulcerative Colitis
NCT02808390Phase 2Terminated
- Sponsor
- PPM Services
- Start
- Nov 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of ged-0507-34-levo in ulcerative colitis (UC), sponsored by PPM Services. Started Nov 2016; status: terminated.
02
Drugs
ged-0507-34-levo
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02808390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02808390.